 Home > Active Ingredient News > Study of Nervous System > Neurology: to assess the risk of corticosteroid use in women after recurrence of IVF multiple sclerosis

Neurology: to assess the risk of corticosteroid use in women after recurrence of IVF multiple sclerosis

 Last Update: 2022-10-12
 Source: Internet
 Author: User

Tags

women strings

control mold 1

Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

Multiple studies have shown that the risk of recurrence after in vitro artificial fertilization (IVF) is increased in women with multiple sclerosis (MS), especially when using the GnRH agonist stimulation regimen

This retrospective cohort study included all patients with multiple sclerosis who

Maintaining DMT until in vitro fertilization appears to be a decisive factor

Source: Mainguy M, Tillaut H, Degremont A, et al.

This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

Related Products

Pregabalin (CNS)

CAS No.: 148553-50-8

Pharmacy Grade

$1/KG FOB

Primidone CAS125-33-7

CAS No.: 125-33-7

Pharmaceutical Grade

$100/KG EXW

API Clomipramine HCl

CAS No.: 17321-77-6

Pharmacy Grade

$40-50/G FOB

Hot Tags

united states jobs(223)

jobs united states(236)

1 year treasury(277)

1 year subscription(296)

single use technology(195)

announcements today(81)

ups united states(221)

united states logo(227)

80 20 company(94)

healthy food name(42)

Hot Articles

The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.